Congrats to @ColumbiaMSPH's Gary Miller, PhD (@GaryWMiller3) for leading a SAMBAI team for #CancerGrandChallenges, addressing cancer disparities by using exposomics to understand influencing environmental, genetic, and social factors.
https://t.co/k3s0ffkn6j
Amazing survival post Haplo transplant for patients with #SCD and the timely question regarding what to do about the vast majority of patients in low and middle income countries who could benefit from this intervention. #globalhealth
It’s not that minority patients aren’t interested (to enroll in clinical trials):
“If you’re never invited, you can’t take interest. If you’re never educated, you can’t take interest.“ Dr. Lucille Adams-Campbell @Georgetown@LombardiCancer@MSKCancerCenter#mskhealthequityCME
“If you’re never invited, how can you be interested?” said Lucile Adams-Campbell regarding minortiy patients and clinical trial enrollment @MSKCancerCenter#Mskhealthequitycme
“We should be having this conversation with everyone… not just people we think are poor” when talking about financial toxicity conversations. @fumikochino poignant comment and shows also the impact of provider biases. #healthequity@MSKCancerCenter